SEER (SEER) Stock Price & Analysis
SEER (SEER) rose 0.52% to USD 1.95 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
SEER last closed at USD 1.95; the session ranged USD 1.93–1.96 on volume of 68,805 shares. Market capitalization is —, with a 52-week range of USD 1.55–2.41 (NMS). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 1.95 |
|---|---|
| Change | ▲ 0.52% (up) |
| Previous Close | USD 1.95 |
| Open | USD 1.95 |
| Day Range | USD 1.93 – 1.96 |
| 52-Week Range | USD 1.55 – 2.41 |
| Volume | 68,805 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SEER)
Nexqual's technical model rates SEER "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.1 (neutral) |
| vs SMA50 | Below (USD 2.05) |
| MACD | -0.03 (negative) |
From SEER's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCAB | BioAtla, Inc. | USD 1.74 | ▲ 43.98% |
| PRLD | Prelude Therapeutics Incorporat | USD 5.46 | ▲ 0.55% |
| MASS | 908 Devices Inc. | USD 10.05 | ▼ 2.71% |
| CERT | Certara, Inc. | USD 7.94 | ▼ 4.11% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.